Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. (2021)

First Author: Conde J
Attributed to:  ZMYND8-regulation of MITF as potential therapeutic target in melanoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acscentsci.1c00070

PubMed Identifier: 34079902

Publication URI: http://europepmc.org/abstract/MED/34079902

Type: Journal Article/Review

Volume: 7

Parent Publication: ACS central science

Issue: 5

ISSN: 2374-7943